4-Bromo-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one, 95+%, 5g

Ethyl 2-(Ethoxymethylene)-4,4,4-trifluoro-3-oxobutyrate>96.0%(GC)5g

2-Propyl-2,3-dihydro-1H-inden-1-one, 97%, 5g

3-Nitroquinolin-4-amine, 95.0%, 1g

5-Chloro-1,2,3,4-tetrahydro-1,6-naphthyridine, 95.0%, 250mg

N-(4-methoxyphenyl)-3-phenylpropanamide, 95.0%, 500mg

2-Fluoro-5-hydroxybenzaldehyde, 95.0%, 10g

Methyl Isonicotinate>99.0%(T)25g

(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 97.0%, 1g

Hexanoic Acid>98.0%(GC)(T)500mL

2-Acrylamido-2-methylpropanesulfonic Acid>98.0%(HPLC)(T)500g

4-(5-Fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(trifluoromethyl)pentane-1,2-diol, 95%, 250mg

(2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoic acid hydrate, 95.0%, 10g